Harrington, P., Dillon, R., Radia, D., Rousselot, P., McLornan, D. P., Ong, M., Green, A., Verde, A., Hussain, F., Raj, K., Kordasti, S., Harrison, C. and de Lavallade, H. (2023) “Differential inhibition of T-cell receptor and STAT5 signaling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia”, Haematologica. Pavia, Italy, 108(6), pp. 1555-1566. doi: 10.3324/haematol.2022.282005.